Clinical trial
Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal…
NCT00346775 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00346775 |
|---|---|
| Title | Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) |
| Official title | A Randomized, Single-Blind, Cross-Over, Multicenter Study to Validate the Preference Module of the Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) Administered to Adult Subjects With Seasonal Allergic Rhinitis During a Three-week Cross-over Study |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | Beclomethasone dipropionate, Flunisolide |
| Enrollment | 97 |
| Start date | May 1, 2006 |
| Primary completion | Jun 29, 2006 |
| Completion | Jun 29, 2006 |
| First posted | Jun 30, 2006 |
| Last update posted | Jan 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: